Literature DB >> 8839390

Identification of a macromolecular crystal growth inhibitor in human urine as osteopontin.

S Sørensen1, S J Justesen, A H Johnsen.   

Abstract

Macromolecules occurring in human urine inhibit the growth and/or aggregation of calcium oxalate crystals and may prevent the formation of kidney stones. Attention has focused particularly on proteins, as these seem to be most responsible for the inhibitory activity; three proteins, nephrocalcin, an unidentified protein rich in uronic acid, and uropontin have all been described as possessing such activity. We have recently isolated an unknown inhibitor of calcium oxalate crystal growth that co-eluted with trypsin inhibitor in several separation steps, which suggested its identity. The aim of the present study was to outline a simple procedure for isolating and identifying this inhibitor. Purification was done as follows: precipitation of the major proteins (albumin and uromucoid) with trichloroacetic acid, followed by anion exchange chromatography, hydroxyapatite chromatography, anion exchange chromatography, negative affinity chromatography, and twice reversed phase chromatographies of the supernatant. By this procedure, the inhibitor was identified as being a fragment of osteopontin; urinary trypsin inhibitor and nucleic acids were excluded as being responsible for inhibitory action.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8839390     DOI: 10.1007/bf00300022

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  27 in total

1.  Urinary crystal surface binding substances on calcium oxalate crystals.

Authors:  T Koide; T Yoshioka; S Yamaguchi; S Hosokawa; M Utsunomiya; T Sonoda
Journal:  Urol Res       Date:  1990

2.  Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin.

Authors:  K Kohri; Y Suzuki; K Yoshida; K Yamamoto; N Amasaki; T Yamate; T Umekawa; M Iguchi; H Sinohara; T Kurita
Journal:  Biochem Biophys Res Commun       Date:  1992-04-30       Impact factor: 3.575

3.  Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.

Authors:  H Shiraga; W Min; W J VanDusen; M D Clayman; D Miner; C H Terrell; J R Sherbotie; J W Foreman; C Przysiecki; E G Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

4.  Inhibitory effects of urinary macromolecules on the crystallization of calcium oxalate.

Authors:  W B Gill; J W Karesh; L Garsin; M J Roma
Journal:  Invest Urol       Date:  1977-09

5.  Acidic peptide and polyribonucleotide crystal growth inhibitors in human urine.

Authors:  H Ito; F L Coe
Journal:  Am J Physiol       Date:  1977-11

6.  Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence.

Authors:  A Oldberg; A Franzén; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine.

Authors:  K A Edyvane; C M Hibberd; R M Harnett; V R Marshall; R L Ryall
Journal:  Clin Chim Acta       Date:  1987-08-31       Impact factor: 3.786

8.  Isolation and characterization of two sialoproteins present only in bone calcified matrix.

Authors:  A Franzén; D Heinegård
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

9.  cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN).

Authors:  M F Young; J M Kerr; J D Termine; U M Wewer; M G Wang; O W McBride; L W Fisher
Journal:  Genomics       Date:  1990-08       Impact factor: 5.736

10.  Role of organic matrix in urinary stone formation: an ultrastructural study of crystal matrix interface of calcium oxalate monohydrate stones.

Authors:  S R Khan; R L Hackett
Journal:  J Urol       Date:  1993-07       Impact factor: 7.450

View more
  5 in total

1.  Distinct immunohistochemical expression of osteopontin in the adult rat major salivary glands.

Authors:  Nicholas Obermüller; Nikolaus Gassler; Norbert Gretz; Bettina Kränzlin; Sigrid Hoffmann; Helmut Geiger; Stefan Gauer
Journal:  J Mol Histol       Date:  2006-07-03       Impact factor: 2.611

2.  Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.

Authors:  Somchai Chutipongtanate; Yasushi Nakagawa; Suchai Sritippayawan; Jeeraporn Pittayamateekul; Paisal Parichatikanond; Bruce R Westley; Felicity E B May; Prida Malasit; Visith Thongboonkerd
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

3.  Growth factors regulate expression of mineral associated genes in cementoblasts.

Authors:  N E Saygin; Y Tokiyasu; W V Giannobile; M J Somerman
Journal:  J Periodontol       Date:  2000-10       Impact factor: 6.993

4.  Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D.

Authors:  Brian Christensen; Lotte Schack; Eva Kläning; Esben S Sørensen
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

5.  The Effect of Polymorphisms in SPP1 on Risk of Fracture: A Case-Control Study.

Authors:  Yanpeng Zhao; Lihai Zhang; Zhi Mao; Yahui Zhang; Xiuyun Su; Yanxiang Cao; Peifu Tang
Journal:  Med Sci Monit       Date:  2015-12-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.